<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Par Pharmaceuticals to Restate Earnings</title>
	<atom:link href="http://stockmarketbeat.com/blog1/2006/07/06/par-to-restate-results-due-to-accounting-errors-reuterscom/feed/" rel="self" type="application/rss+xml" />
	<link>http://stockmarketbeat.com/blog1/2006/07/06/par-to-restate-results-due-to-accounting-errors-reuterscom/</link>
	<description>Our beat: The stock market. Our job: Beat it.</description>
	<lastBuildDate>Tue, 03 Jun 2008 15:36:49 -0600</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.1</generator>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<item>
		<title>By: Dr.Lord</title>
		<link>http://stockmarketbeat.com/blog1/2006/07/06/par-to-restate-results-due-to-accounting-errors-reuterscom/comment-page-1/#comment-28145</link>
		<dc:creator>Dr.Lord</dc:creator>
		<pubDate>Thu, 03 May 2007 01:07:58 +0000</pubDate>
		<guid isPermaLink="false">http://stockmarketbeat.com/blog1/2006/07/06/par-to-restate-results-due-to-accounting-errors-reuterscom/#comment-28145</guid>
		<description>&lt;a&gt;&lt;/a&gt;</description>
		<content:encoded><![CDATA[<p><a></a></p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Bad Debt and the Allowance for Doubtful Accounts - Financial Education - Everything You Need To Know About Finance</title>
		<link>http://stockmarketbeat.com/blog1/2006/07/06/par-to-restate-results-due-to-accounting-errors-reuterscom/comment-page-1/#comment-22216</link>
		<dc:creator>Bad Debt and the Allowance for Doubtful Accounts - Financial Education - Everything You Need To Know About Finance</dc:creator>
		<pubDate>Thu, 29 Mar 2007 19:16:38 +0000</pubDate>
		<guid isPermaLink="false">http://stockmarketbeat.com/blog1/2006/07/06/par-to-restate-results-due-to-accounting-errors-reuterscom/#comment-22216</guid>
		<description>[...] Companies have a fair amount of discretion regarding how they will estimate their losses from customers who fail to pay, and when they will recognize the losses. This article, originally published at Stock Market Beat and reprinted here with the author&#8217;s permission, offers a nuts-and-bolts explanation of how investors can make any necessary adjustments. Another article at Stock Market Beat explains why this is important. [...]</description>
		<content:encoded><![CDATA[<p>[...] Companies have a fair amount of discretion regarding how they will estimate their losses from customers who fail to pay, and when they will recognize the losses. This article, originally published at Stock Market Beat and reprinted here with the author&#8217;s permission, offers a nuts-and-bolts explanation of how investors can make any necessary adjustments. Another article at Stock Market Beat explains why this is important. [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Carnival of Investing #30 &#124; Experiments in Finance</title>
		<link>http://stockmarketbeat.com/blog1/2006/07/06/par-to-restate-results-due-to-accounting-errors-reuterscom/comment-page-1/#comment-371</link>
		<dc:creator>Carnival of Investing #30 &#124; Experiments in Finance</dc:creator>
		<pubDate>Mon, 10 Jul 2006 07:01:38 +0000</pubDate>
		<guid isPermaLink="false">http://stockmarketbeat.com/blog1/2006/07/06/par-to-restate-results-due-to-accounting-errors-reuterscom/#comment-371</guid>
		<description>[...] Stock Market Beat goes through a detailed example of accounts receivables monitoring related to Par Pharmaceutical&#8217;s earnings restatement.    JeffSHoward explains the drawbacks and benefits of buying individual bonds vs. bond funds. [...]</description>
		<content:encoded><![CDATA[<p>[...] Stock Market Beat goes through a detailed example of <a href="http://financial-education.com/2007/01/31/accounts-receivable-turnover-and-days-sales-outstanding/">accounts receivable</a>s monitoring related to Par Pharmaceutical&#8217;s earnings restatement.    JeffSHoward explains the drawbacks and benefits of buying individual bonds vs. bond funds. [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

